Y-Intercept (HK)’s Maravai LifeSciences MRVI Stock Holding History

Y-Intercept (HK)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.28M	Buy	+167,399	New	+$1.16M	0.03%	873
2026 Q2	–	Sell	-13,113	Closed	-$37.1K	–	2007
2026 Q1	$37.1K	Buy	+13,113	New	+$44.5K	﹤0.01%	1491
2025 Q4	–	Sell	-33,775	Closed	-$96.9K	–	1847
2025 Q3	$96.9K	Buy	+33,775	New	+$86.2K	﹤0.01%	1492
2025 Q1	–	Sell	-32,359	Closed	-$176K	–	1470
2024 Q4	$176K	Buy	32,359 +19,713	+156%	+$127K	0.01%	1064
2024 Q3	$105K	Buy	+12,646	New	+$109K	0.01%	1209
2024 Q2	–	Sell	-99,813	Closed	-$865K	–	1728
2024 Q1	$865K	Buy	99,813 +42,507	+74%	+$288K	0.07%	445
2023 Q4	$375K	Buy	57,306 +33,812	+144%	+$218K	0.03%	735
2023 Q3	$235K	Buy	+23,494	New	+$258K	0.02%	859
2023 Q2	–	Sell	-50,060	Closed	-$701K	–	1556
2023 Q1	$701K	Sell	50,060 -3,116	-6%	-$44.8K	0.08%	383
2022 Q4	$761K	Buy	+53,176	New	+$837K	0.11%	284
2022 Q3	–	Sell	-17,351	Closed	-$493K	–	1163
2022 Q2	$493K	Buy	17,351 +9,596	+124%	+$304K	0.06%	430
2022 Q1	$274K	Buy	+7,755	New	+$260K	0.06%	484
2021 Q4	–	Sell	-10,216	Closed	-$501K	–	771
2021 Q3	$501K	Buy	10,216 +1,786	+21%	+$87.1K	0.09%	331
2021 Q2	$352K	Buy	+8,430	New	+$327K	0.09%	361

Other funds holding MRVI

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Y-Intercept (HK)'s MRVI Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 167,399 shares worth $1.28M. The stake represents 0.03% of the portfolio and ranks #873 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in MRVI as recently as Q1 2026.

Y-Intercept (HK) first reported a position in MRVI in Q2 2021 and has held it in 14 quarters since. 14 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

Y-Intercept (HK) held 167,399 shares of Maravai LifeSciences worth $1.28M as of Q3 2026.
Maravai LifeSciences was a new Y-Intercept (HK) position in Q3 2026.
Maravai LifeSciences made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #873 holding.
Y-Intercept (HK) first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 14 quarters since.
14 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.